NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Addendum to Psychosis and schizophrenia in children and young people. London: National Institute for Health and Care Excellence (NICE); 2016 May. (Clinical Guideline Addendum, No. 155.1.)
Databases that were searched, together with the number of articles retrieved from each database are shown in Table 16. The search strategy is shown in Table 17. A similar strategy was translated for the other databases listed.
Table 16Economic search summary
| Economics | Version/files | No. retrieved |
|---|---|---|
| MEDLINE (Ovid) | Ovid MEDLINE(R) 1946 to October Week 1 2015 | 71 |
| MEDLINE in Process (Ovid) | Ovid MEDLINE(R) In-Process & Other Non-Indexed Citations October 12, 2015 | 53 |
| Embase (Ovid) | Embase 1974 to 2015 Week 41 | 583 |
| NHS Economic Evaluation Database (NHS EED) (legacy database) | NHS Economic Evaluation Database : Issue 2 of 4, April 2015 | 31 |
| Health Technology Assessment (HTA Database) | Health Technology Assessment Database : Issue 3 of 4, July 2015 | 5 |
| PubMed | - | 59 |
Table 17Economic search strategy
| Database: Medline |
|---|
| Strategy used: |
| 1 exp “schizophrenia and disorders with psychotic features”/ (123611) |
| 2 schizophrenia, childhood/ (1490) |
| 3 delusions/ (6779) |
| 4 hallucinations/ (9503) |
| 5 (delusion* or hallucinat* or hebephreni* or oligophreni* or paranoi* or paraphreni* or psychotic* or psychosis or psychoses or schizo*).tw. (148878) |
| 6 or/1–5 (183749) |
| 7 olanzapine*.tw. (6132) |
| 8 (aedon or amulsin or anzatric or anzorin or apsico or apzet or arenbil or arkolamyl or asterilon or atyzyo or axonium or bloonis or caprilon or cinol or clingozan or dopin or elynza or enolex or epilanz or expolid or exzapine or fordep or fredilan or jolyon or joyzol or kynapine or lano or lanopin or lansyn or lanza* or lanzek or lapenza or lapozan or lazap* or lupilan or ly170053 or manza or meltolan or midax or m-olan or neupine or newzypra or niolib or nolian or normiton or nykob or nylsanuc or nyzol or ofans or oferta or olace or oladay or olafer or olafid or olan* or olapax or olapin* or olastazen or olasyn or olaxinn or olazofren or olazax or oleanz or olenxa or oles or olexar or olfrex or olima or olivin or oliza or ollafax or olmyzem or olnegis or olpin* or oltal or olzadin or olzanid or olzap* or olzin or onezyp or onza* or opin or opinox or opirap or oxatech or ozace or ozap* or ozilormar or ozin or parnassan or parnasan or pinolza or psycholanz or psychozap or ranofren or redilanz or relprevv or remittal or rexapin or revertrix or rolanzax or rolyprexa or sanza or sartina or simina or sincris or stygapon or synza or tanssel or tolanz or villamos or xoltiva or zalasta or zalepin or zamil or zanprex or zap or zapilux or zapinex or zappa or zapris or zelta or zeprex or zerpi or zolafren or zolapine or zolaxa or zonapi* or zophix or zopina or zopix or zopridoxin or zoxil or zydis or zylanza or zylap or zypadhera or zypefar or zypine or zyprex* or zyzapin).tw. (8973) |
| 9 (ly adj4 “170053”).tw. (2) |
| 10 or/7–9 (8973) |
| 11 6 and 10 (3830) |
| 12 Animals/ not Humans/ (4033465) |
| 13 11 not 12 (3487) |
| 14 limit 13 to english language (3221) |
| 15 limit 14 to ed=20120101-20151031 (607) |
| 16 Economics/ (27199) |
| 17 exp “Costs and Cost Analysis”/ (194377) |
| 18 Economics, Dental/ (1887) |
| 19 exp Economics, Hospital/ (20822) |
| 20 exp Economics, Medical/ (13966) |
| 21 Economics, Nursing/ (3955) |
| 22 Economics, Pharmaceutical/ (2637) |
| 23 Budgets/ (10205) |
| 24 exp Models, Economic/ (11174) |
| 25 Markov Chains/ (10978) |
| 26 Monte Carlo Method/ (22012) |
| 27 Decision Trees/ (9399) |
| 28 econom$.tw. (169950) |
| 29 cba.tw. (8989) |
| 30 cea.tw. (17210) |
| 31 cua.tw. (825) |
| 32 markov$.tw. (12889) |
| 33 (monte adj carlo).tw. (22718) |
| 34 (decision adj3 (tree$ or analys$)).tw. (9170) |
| 35 (cost or costs or costing$ or costly or costed).tw. (333573) |
| 36 (price$ or pricing$).tw. (24919) |
| 37 budget$.tw. (18407) |
| 38 expenditure$.tw. (37694) |
| 39 (value adj3 (money or monetary)).tw. (1441) |
| 40 (pharmacoeconomic$ or (pharmaco adj economic$)).tw. (2976) |
| 41 or/16–40 (704982) |
| 42 “Quality of Life”/ (132361) |
| 43 quality of life.tw. (153758) |
| 44 “Value of Life”/ (5517) |
| 45 Quality-Adjusted Life Years/ (8051) |
| 46 quality adjusted life.tw. (6804) |
| 47 (qaly$ or qald$ or qale$ or qtime$).tw. (5557) |
| 48 disability adjusted life.tw. (1415) |
| 49 daly$.tw. (1372) |
| 50 Health Status Indicators/ (21128) |
| 51 (sf36 or sf 36 or short form 36 or shortform 36 or sf thirtysix or sf thirty six or shortform thirtysix or shortform thirty six or short form thirtysix or short form thirty six).tw. (16740) |
| 52 (sf6 or sf 6 or short form 6 or shortform 6 or sf six or sfsix or shortform six or short form six).tw. (1057) |
| 53 (sf12 or sf 12 or short form 12 or shortform 12 or sf twelve or sftwelve or shortform twelve or short form twelve).tw. (3006) |
| 54 (sf16 or sf 16 or short form 16 or shortform 16 or sf sixteen or sfsixteen or shortform sixteen or short form sixteen).tw. (22) |
| 55 (sf20 or sf 20 or short form 20 or shortform 20 or sf twenty or sftwenty or shortform twenty or short form twenty).tw. (342) |
| 56 (euroqol or euro qol or eq5d or eq 5d).tw. (4519) |
| 57 (qol or hql or hqol or hrqol).tw. (27689) |
| 58 (hye or hyes).tw. (60) |
| 59 health$ year$ equivalent$.tw. (38) |
| 60 utilit$.tw. (123006) |
| 61 (hui or hui1 or hui2 or hui3).tw. (929) |
| 62 disutili$.tw. (242) |
| 63 rosser.tw. (71) |
| 64 quality of wellbeing.tw. (5) |
| 65 quality of well-being.tw. (349) |
| 66 qwb.tw. (179) |
| 67 willingness to pay.tw. (2531) |
| 68 standard gamble$.tw. (696) |
| 69 time trade off.tw. (803) |
| 70 time tradeoff.tw. (220) |
| 71 tto.tw. (644) |
| 72 or/42–71 (350481) |
| 73 41 or 72 (1007707) |
| 74 15 and 73 (71) |
- NICE Clinical Guideline 155: Psychosis and Schizophrenia in Children and Young People: Recognition and Management
- Psychosis and schizophrenia in children and young people: Evidence Update March 2015: A summary of selected new evidence relevant to NICE clinical guideline 155 'Psychosis and schizophrenia in children and young people: recognition and management' (2013)
- Surveillance report 2016 - Psychosis and schizophrenia in children and young people: recognition and management (2013) NICE guideline CG155
- Economic search strategy - Addendum to Psychosis and schizophrenia in children a...Economic search strategy - Addendum to Psychosis and schizophrenia in children and young people
Your browsing activity is empty.
Activity recording is turned off.
See more...